Gene · 10460
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Virus-mediated gene fusion: igniting and sustaining oncogenesis. | Trends Cancer | 2025 | 41207822 | PubTator, text mining | PubMed |
| Risk model of liquid-liquid phase separation-related genes reveals the prognosis and tumor microenvironment characteristics of colorectal cancer. | J Cell Commun Signal | 2025 | 41194971 | PubTator, text mining | PubMed |
| [Clinicopathological and molecular genetic heterogeneity of diffuse gliomas with the features of polymorphous low-grade neuroepithelial tumor of the young]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 41183817 | PubTator, text mining | PubMed |
| Diffuse glioma with FGFR3-TACC3 fusion in adults is not a homogenous clinicopathological and molecular entity. | J Pathol Clin Res | 2025 | 41165398 | PubTator, text mining | PubMed |
| Intranuclear paraspeckle-circular RNA TACC3 assembly forms RNA-DNA hybrids to facilitate MASH-related hepatocellular carcinoma growth in an m6A-dependent manner. | Cancer Commun (Lond) | 2025 | 41103024 | PubTator, text mining | PubMed |
| Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 results. | Oncologist | 2025 | 41100064 | PubTator, text mining | PubMed |
| A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomas. | Neurooncol Pract | 2025 | 41080200 | PubTator, text mining | PubMed |
| FGFR3 alteration sites and response rate to FGFR inhibitors in urothelial carcinoma. | Pharmacol Res | 2025 | 41005586 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank. | Bladder Cancer | 2025 | 40978103 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptor 3 Alteration Status and Outcomes on Immune Checkpoint Inhibitors in Patients With Metastatic Urothelial Carcinoma. | JCO Precis Oncol | 2025 | 40956998 | PubTator, text mining | PubMed |
| The mechanisms of MTOCs maturation in human and mouse oocytes. | Sci Bull (Beijing) | 2025 | 40903356 | PubTator, text mining | PubMed |
| Transforming acidic coiled-coil-containing protein 3-mediated lipid metabolism reprogramming impairs CD8+ T-cell cytotoxicity in hepatocellular carcinoma. | Signal Transduct Target Ther | 2025 | 40866361 | PubTator, text mining | PubMed |
| Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer-A Narrative Review. | Curr Oncol | 2025 | 40862817 | PubTator, text mining | PubMed |
| Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer. | J Med Virol | 2025 | 40832845 | PubTator, text mining | PubMed |
| Identification of hypoxia-related diagnostic biomarkers and immune signatures in diminished ovarian reserve. | Front Genet | 2025 | 40832468 | PubTator, text mining | PubMed |
| Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. | J Transl Med | 2025 | 40804394 | PubTator, text mining | PubMed |
| Biallelic variants in DLGAP5 cause spindle assembly defects and human early embryonic arrest. | Hum Reprod | 2025 | 40796344 | PubTator, text mining | PubMed |
| Tumor location, genomic alterations, and radiomic features as predictors of survival in glioblastoma: a Multi-Modal analysis. | Neuroradiology | 2025 | 40794131 | PubTator, text mining | PubMed |
| Integrative machine learning and bioinformatics analysis to identify cellular senescence-related genes and potential therapeutic targets in ulcerative colitis and colorectal cancer. | Front Bioinform | 2025 | 40791849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10460/papers?page=3